Clinical Research Directory
Browse clinical research sites, groups, and studies.
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Summary
Background: COVID-19 is an acute respiratory syndrome. One symptom of COVID-19 is a reduction in the number of cells called lymphocytes in the blood. Lymphocytes are a type of white blood cell that fights infections. With fewer lymphocytes, the body cannot effectively fight back against SARS CoV-2, the virus that causes COVID-19. Researchers want to better understand how SARS-CoV-2 affects these blood cells. This information may give them ideas for new treatments. Objective: To learn more about how SARS-CoV-2 affects lymphocytes, the immune, and the blood clotting system. Eligibility: Adults age 18 and older who either currently have COVID-19 or have recently recovered from it Design: Participants will give a blood sample. For this, a needle is used to collect blood from an arm vein. For participants who have a central line, blood will be collected through that instead. Participants medical records related to COVID-19 will be reviewed. Participants who have recovered from COVID-19 will be asked to undergo leukapheresis to collect white blood cells. For this, blood is taken from a needle placed in one arm. A machine separates out the white blood cells. The rest of the blood is returned to the participant through a needle placed in the other arm. This takes about 2-3 hours. Recovered participants may have material collected from inside the nostrils and/or rectum. This is done by gently rubbing the area with a sterile cotton swab. Recovered participants may have an echocardiogram to look at their heart. For this, a small probe is held against the chest to get pictures of the heart from different angles. This takes less than 30 minutes. Participation lasts 1-2 days on most cases and may be split in a few visits for recovered patients if leukapheresis and echocardiogram are done. ...
Official title: COVID-19-Associated Lymphopenia Pathogenesis Study in Blood
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
240
Start Date
2020-05-22
Completion Date
2025-02-24
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Locations (3)
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, United States
MedStar Health Research Institute: Washington Hospital Medical Center
Washington D.C., District of Columbia, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States